Funding profile · Veterinary healthcare IT
Furmacy
A Y Combinator seed company that was bought by a public pet company for stock in 2022 and sold again for undisclosed cash in 2025. There is no Form D on Furmacy’s own record; almost everything here comes from its buyer’s SEC filings and both companies’ press releases.
$125KSeed round, 2021, Y Combinator, per a company data tracker
$0.43MValue of Wag! Group Co.’s all stock acquisition, Oct 24, 2022
90,000Wag common shares issued as acquisition consideration
UndisclosedCash price MWI Animal Health paid for Furscription, Jul 14, 2025
Data as of September 25, 2026. Company-reported figures are labeled.
Rounds at a glance
| When | Round | Amount | Investors | Source |
|---|---|---|---|---|
| 2021 | Seed, Y Combinator Winter 2021 | $125,000, per Tracxn | Y Combinator | Data tracker |
| Oct 24, 2022 | Acquisition by Wag! Group Co. | $0.43M in about 90,000 shares of Wag common stock | Wag! Group Co. (Nasdaq: PET) | SEC 10-K |
| Jul 14, 2025 | Sale of the Furscription business to MWI | Cash consideration, amount not disclosed | MWI Veterinary Supply Co. | Press release |
What the filings show
Wag! Group Co. · Form 10-K, fiscal year 2022 · filed 2023
- Transaction
- 100% acquisition of Furmacy, Inc., completed Oct 24, 2022
- Consideration
- About 90,000 shares of Wag common stock, issued before Nov 4, 2022, the effective date of Wag’s registration statement
- Value at close
- Approximately $0.43 million, per S&P Capital IQ data
- Materiality
- Described by Wag as not material to the company
- Assets assumed
- Two operating leases in El Dorado Hills, CA, an office and a warehouse, about 13 months remaining at acquisition
- Revenue contribution
- $0.1 million included in Wag’s Wellness segment revenue for the two months following the acquisition in FY2022
- Filing
- SEC EDGAR, Wag! Group Co., CIK 0001842356
No Form D was found under Furmacy, Inc.’s own name in SEC EDGAR. The detail above comes from its acquirer’s annual report, not from a notice of Furmacy’s own securities offering.
Reading the filings
- Furmacy never filed its own Form D.The only SEC paper trail runs through Wag’s 10-K, filed as the buyer, not through any offering notice filed by Furmacy itself. Companies that raise only from an accelerator and angels sometimes never trigger a Form D, so the gap does not prove no other money moved.
- The 2022 deal was small for both sides.Ninety thousand Wag shares worth about $0.43 million works out to roughly $86,000 per employee if Furmacy still had the five people Y Combinator’s listing counts. Wag itself called the acquisition not material.
- The pharmacy did not survive the deal.Within about seven months of closing, Wag had shut the El Dorado Hills pharmacy operation it assumed, keeping only the prescribing software and letting the physical fulfillment side go.
- The 2025 sale disclosed no price.Unlike the 2022 acquisition, which Wag had to report because it is a public company, the 2025 sale to MWI, a private distributor, came with no required number. Both the Wag and MWI press releases describe the payment only as cash consideration.
- Headcount shrank between owners.Four Wag employees moved to MWI in the 2025 sale, the only headcount figure disclosed for that transaction and fewer than the five people on Furmacy’s team when Y Combinator last updated its listing three years earlier.
Commercial signals
| Signal | Detail | Source type |
|---|---|---|
| Regulatory | Not applicable. Furmacy and Furscription are prescribing software and pharmacy distribution, not an FDA regulated device. | Not applicable |
| Customers | No paying clinic customer named by Furmacy, Wag, or MWI. | Not found |
| Distribution | Letter of intent to integrate with an unnamed platform said to serve thousands of clinics, announced Apr 2024. | Company-stated |
| Pricing | MWI lists Furscription at $75 a month introductory and $50 a month at a loyalty rate, 12 month commitment, unlimited users. | Company-stated |
| Headcount | Four Wag employees transferred to MWI as part of the Jul 2025 sale. | Company-stated |
What to watch
- Whether MWI publishes clinic counts or revenue for Furscription now that it sits inside a distributor’s broader technology suite.
- Whether the unnamed platform integration Wag announced in Apr 2024 was ever completed.
- Whether an amended or late Form D ever appears under Furmacy, Inc.’s name in SEC EDGAR.
- Where Georgia and Alex Jeremiah went after the 2025 sale. Neither founder’s next role turned up in this review.
The Furmacy story on Healthcare DiscoveryHealthcare Discovery
Related companies
Sources
- Public recordForm 10-K for fiscal year 2022
- IndependentWag! Group Co. agreed to acquire Furmacy, inc.
- IndependentWag! Group Co. completed the acquisition of Furmacy, inc. for $0.43 million
- IndependentWag Group shutters El Dorado Hills pet pharmacy after acquisition of Furmacy
- CompanyWag! Launches Furscription, a Revolutionary Software Solution to Solve the Veterinary Prescription Headache
- CompanyWag! Group Co. Announces Sale of Furscription to MWI Veterinary Supply Co.
- PartnerMWI Animal Health Expands Technology Solutions for Veterinary Practices with Addition of Furscription
- IndependentMWI Animal Health Acquires Furscription
- Independent, limited dataFurmacy company profile and funding
- CompanyFurscription product and pricing page
Compiled from SEC and other public records and published reports as of September 25, 2026. Form D notices report offerings under Regulation D; none was found under Furmacy, Inc.’s own name, so the funding detail above draws on its acquirer’s SEC filings and both companies’ announcements instead. Healthcare Venture Capital Fund holds no position in Furmacy. This page is not an offer to sell or a recommendation to buy any security.